Lomardexamfetamine structure
|
Common Name | Lomardexamfetamine | ||
|---|---|---|---|---|
| CAS Number | 1032291-80-7 | Molecular Weight | 305.42 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | N/A | |
| Molecular Formula | C16H27N5O | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of LomardexamfetamineLomardexamfetamine (KP 106) is an orally active central nervous system stimulant composed of d-amphetamine and a ligand. Lomardexamfetamine can be used for the research of attention-deficit hyperactivity disorder[1]. |
| Name | N6-Carbamimidoyl-N-[(2S)-1-phenyl-2-propanyl]-L-lysinamide |
|---|---|
| Synonym | More Synonyms |
| Description | Lomardexamfetamine (KP 106) is an orally active central nervous system stimulant composed of d-amphetamine and a ligand. Lomardexamfetamine can be used for the research of attention-deficit hyperactivity disorder[1]. |
|---|---|
| Related Catalog | |
| In Vitro | Lomardexamfetamine is an orally active central nervous system stimulant composed of d-amphetamine and a ligand[1]. |
| References |
[1]. KemPharm, Inc. Announces Plans to Launch KP106 as First Oral Film Dosage Form for ADHD |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Molecular Formula | C16H27N5O |
| Molecular Weight | 305.42 |
| Exact Mass | 305.221558 |
| LogP | -0.11 |
| Index of Refraction | 1.584 |
| Hexanamide, 2-amino-6-[(aminoiminomethyl)amino]-N-[(1S)-1-methyl-2-phenylethyl]-, (2S)- |
| N6-Carbamimidoyl-N-[(2S)-1-phenyl-2-propanyl]-L-lysinamide |